Standards, Options and Recommendations (SOR) for clinical care of squamous cell carcinoma of the oropharynx

被引:0
|
作者
Renaud-Salis, JL
Blanc-Vincent, MP
Brugère, J
Demard, F
Faucher, A
Gory-Delabaere, G
Pinsolle, J
机构
[1] SOR, FNCLCC, Operat Stand, F-75654 Paris 13, France
[2] Inst Bergonie, Bordeaux, France
[3] Inst Curie, Paris, France
[4] Ctr Antoine Lacassagne, F-06054 Nice, France
[5] Hop Pellegrin, F-33076 Bordeaux, France
关键词
oropharynx cancer; guidelines; cancer; neoplasms; adult; surgery; chemotherapy; radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of the French Cancer Centres (FNCLCC), the 20, French Cancer Centres and specialists from French Public Universities, General Hospitals and Private Clinics. The main objective is the development of clinical practice guidelines to improve the quality of health care and outcome for cancer patients. The methodology is based on literature systematic review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery. Objectives: To develop clinical practice guidelines according to the definitions of Standards, Options and Recommendations for the management of squamous carcinoma of the oropharynx. Methods: Data have been identified by literature search using Medline (1991-1998) and the expert groups personal reference lists. Once the guidelines were defined, the document was submitted for review to national and international independent reviewers and to the medical committees of the 20 French Cancer Centres. Results: The main recommendations for squamous cell carcinoma of the oropharynx management are that: 1) diagnosis and initial assessment should be based on appropriate clinical and radiological findings; 2) the therapeutic strategy is based on surgery, radiotherapy, bradytherapy and chemotherapy; 3) in limited tumours, the recommended strategy involved the use of one of these modality; 4) a multimodality approach is recommended for the treatment of extended resecable tumours. Following results of recent meta-analyses, use of neo-adjuvant chemotherapy is not recommended The same studies have shown that association of chemotherapy and radiotherapy either in sequence or in combination significantly improve survival of extended curable tumours. These associations are recommended within the framework of clinical trials; 5) follow-up of squamous carcinoma of the oropharynx should involve physical examination of the upper aerodigestive tract and the lymph nodes areas every three months during the first year, every six months during the second year and then every year An annual chest x-ray is recommended. Other investigations should be performed as indicated by symptoms and clinical manifestations.
引用
收藏
页码:550 / 572
页数:23
相关论文
共 50 条
  • [31] Standards, options and recommendations (SOR) for the management of neutropenic cancer patients (excluding prolonged neutropenia)
    Biron, P
    Fuhrmann, C
    Escande, MC
    Blanc-Vincent, MP
    Crokaert, F
    Beal, J
    Bussy, V
    Lesimple, T
    Pottecher, B
    Raveneau, J
    Senet, JM
    Viot, M
    BULLETIN DU CANCER, 1998, 85 (08) : 695 - 711
  • [32] Standards, Options and Recommendations for the surgical management of carcinoma of the endometrium
    Brémond, A
    Bataillard, A
    Thomas, L
    Achard, JL
    Fervers, B
    Fondrinier, É
    Lansac, J
    Bailly, C
    Hoffstetter, S
    Basuyau, JP
    d'Anjou, J
    Descamps, P
    Farsi, F
    Guastalla, JP
    Laffargue, F
    Rodier, JF
    Vincent, P
    Pigneux, J
    BULLETIN DU CANCER, 2001, 88 (02) : 181 - 198
  • [33] Standards, Options and Recommendations (SOR) for the perioperative treatment of operable patients with resecable non small cell lung cancer (update)
    Besse, Benjamin
    Depierre, Alain
    Guillo, Sylvie
    Guerche, Clotilde Seblain-El
    Douillard, Jeari-Yves
    Ginies, Annie
    Hennequin, Christophe
    Le Pechoux, Cecile
    Milleron, Bernard
    Moro-Sibilot, Denis
    MOUillefarine, Pierre
    Quoix, Elisabeth
    Regnard, Jean-Francois
    Riquet, Marc
    Vaylet, Fabien
    Zalcman, Gerard
    BULLETIN DU CANCER, 2007, 94 (10) : 887 - 896
  • [34] Standards, Options and Recommendations (SOR) for the perioperative treatment of operable patients with resecable non-small cell lung cancer
    Besse, Benjamin
    Depierre, Alain
    Guillo, Sylvie
    Guerche, Clotilde Seblain-El
    Douillard, Jean-Yves
    Ginies, Annie
    Hennequin, Christophe
    Le Pechoux, Cecile
    Milleron, Bernard
    Moro-Sibilot, Denis
    Mouillefarine, Pierre
    Quoix, Elisabeth
    Regnard, Jean-Francois
    Riquet, Marc
    Vaylet, Fabien
    Zalcman, Gerard
    ONCOLOGIE, 2007, 9 (11) : 800 - 809
  • [35] Basaloid squamous cell carcinoma of oral cavity and oropharynx
    Altavilla, G
    Mannarà, GM
    Rinaldo, A
    Ferlito, A
    ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1999, 61 (03): : 169 - 173
  • [36] SQUAMOUS-CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX
    LINDBERG, RD
    EAR NOSE & THROAT JOURNAL, 1977, 56 (03): : 26 - &
  • [37] NEOPLASTIC SEEDING OF SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX
    CLAYMAN, G
    COHEN, JI
    ADAMS, GL
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1993, 15 (03): : 245 - 248
  • [38] Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx
    Obata, A
    Eura, M
    Sasaki, J
    Saya, H
    Chikamatsu, K
    Tada, M
    Iggo, RD
    Yumoto, E
    INTERNATIONAL JOURNAL OF CANCER, 2000, 89 (02) : 187 - 193
  • [39] Large Cell Carcinoma of the Lung and Squamous Cell Carcinoma of the Oropharynx Presenting as Uveitis
    Lesniak, Aleksandra
    Hodge, William G.
    ANNALS OF OPHTHALMOLOGY, 2009, 41 (01) : 52 - 54
  • [40] Clinical significance of expression of cripto-1 in patients of squamous cell carcinoma of oropharynx
    Kumar, M. S.
    Pal, A.
    Jain, A.
    Ghoshal, S.
    Rai, B.
    Mohindra, S.
    Das, A.
    ANNALS OF ONCOLOGY, 2016, 27